Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer
- Abstract views: 1387
- PDF: 849
Copyright (c) 2016 Gianpaolo Perletti
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.